EUVIMEDEUVIMED entdecken
Crossref

Prevalence of sarcopenia and individual- and country-level risk factors in 36 countries: pooled analysis of nationally representative individual data

Simu Huang, Wenyu Lai iD, David Flood, Yuding Wei, Yu Zheng, Qitong Liu, Haoying Ren, Suyue Xiong, Norma Mansor, Huijing He, Meihong Xu, Lianggong Ding und 5 weitere

Age and Ageing · 02.07.2026 · 55 (7)

DOI: 10.1093/ageing/afag210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 23.07.2026. Verfasst von Simu Huang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Science and Technology Development Fund in Macau, Centre for Pharmaceutical Regulatory Sciences, University of Macau, Institute of Chinese Medical Sciences, University of Macau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia is an age-related condition that contributes to disability and healthcare burden worldwide. Yet cross-national evidence on prevalence and multi-level risk factors is limited.

Methods

We pooled data from 10 nationally representative or population-based ageing studies, including 144 226 adults aged ≥50 years from 36 high- and middle-income countries. Sarcopenia and severe sarcopenia were defined using 2019 revised European Working Group on Sarcopenia in Older People criteria. Prevalence was standardised by age and gender within each country. We examined associations between sarcopenia and individual-level sociodemographic and health characteristics, and country-level socioeconomic indicators.

Results

Sarcopenia prevalence ranged from 2.1% to 17.4% across 36 countries, with 16 countries above 5.0% and three above 10.0%. Approximately 92.7 million of 1.07 billion adults ≥50 in these countries were projected to have sarcopenia. At the individual-level, higher risk was associated with older age, gender (men), lower education, being unmarried or not partnered, non-full-time employment, lower household wealth, current smoking, non-recent drinking, physical inactivity and ≥2 chronic diseases (e.g. men: RR = 1.47; 95% CI: 1.32, 1.64). At the country-level, higher gross domestic product (GDP) per capita, higher Gender Development Index and lower Labor Force Participation Rate were associated with lower sarcopenia risk (e.g. GDP per capita: RR = 0.42; 95% CI: 0.30, 0.60).

Conclusion

Sarcopenia varies widely across countries and is more common in middle-income than high-income settings, pointing to a pattern shaped by both personal and contextual conditions. Addressing the emerging burden of sarcopenia will require integrated strategies targeting modifiable risk factors while tackling contextual and structural inequalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaHumansRisk FactorsPrevalenceFemaleMaleAgedMiddle AgedAge FactorsAged, 80 and overGlobal HealthSocioeconomic FactorsDeveloped Countries

Stichwörter der Autor:innen

cross-country comparisonmiddle-aged and older adultsolder peopleprevalencerisk factorssarcopenia

Autor:innen und Institutionen

  • Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
  • Division of Hospital Medicine, Department of Internal Medicine, National Clinician Scholars Program, University of Michigan, Ann Arbor, Michigan, USA.
  • Social Wellbeing Research Centre, Universiti Malaya, Kuala Lumpur, Malaysia.
  • Department of Epidemiology and Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Common Mechanism Research for Major Diseases, Beijing, China.
  • Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing, China.

ORCID-Profile: Wenyu Lai, Peiyi Lu, Yuanjia Hu, Chihua Li

Förderung

  • Science and Technology Development Fund in Macau
  • Centre for Pharmaceutical Regulatory Sciences, University of Macau
  • Institute of Chinese Medical Sciences, University of Macau

Zitieren

APA

Huang, S., Lai, W., Flood, D., Wei, Y., Zheng, Y., Liu, Q., Ren, H., Xiong, S., Mansor, N., He, H., Xu, M., Ding, L., Liu, M., Hu, H., Lu, P., Hu, Y., & Li, C. (2026). Prevalence of sarcopenia and individual- and country-level risk factors in 36 countries: pooled analysis of nationally representative individual data. Age and Ageing, 55(7). https://doi.org/10.1093/ageing/afag210

Vancouver

Huang S, Lai W, Flood D, Wei Y, Zheng Y, Liu Q, et al. Prevalence of sarcopenia and individual- and country-level risk factors in 36 countries: pooled analysis of nationally representative individual data. Age and Ageing. 2026;55(7). doi:10.1093/ageing/afag210

BibTeX
@article{Huang2026,
  author = {Huang, Simu and Lai, Wenyu and Flood, David and Wei, Yuding and Zheng, Yu and Liu, Qitong and Ren, Haoying and Xiong, Suyue and Mansor, Norma and He, Huijing and Xu, Meihong and Ding, Lianggong and Liu, Mingxuan and Hu, Hao and Lu, Peiyi and Hu, Yuanjia and Li, Chihua},
  title = {Prevalence of sarcopenia and individual- and country-level risk factors in 36 countries: pooled analysis of nationally representative individual data},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {7},
  doi = {10.1093/ageing/afag210}
}
Kostenlos starten →